Volpara to supply cancer diagnostics SW to Intermountain Health

Lunit's subsidiary provides breast cancer screening software to the US-based nonprofit healthcare system

Volpara to supply cancer diagnostics SW to Intermountain Health
Yoo-Rim Kim 1
2024-08-21 17:01:54 youforest@hankyung.com
Bio & Pharma

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software developer for breast cancer detection, which was acquired last May, signed a contract to supply breast cancer screening software to the US healthcare system Intermountain Health.

The products to be supplied include three of Volpara's flagship software: Risk Pathways, Analytics. and Scorecard.

These products will be used for cancer risk assessment, breast tissue density evaluation, and the improvement of mammography quality.

Intermountain Health is the largest nonprofit healthcare system in the western United States, operating 34 hospitals and over 400 clinics across seven states, including Utah, Idaho, and Nevada.

Write to Yoo-Rim Kim at youforest@hankyung.com

Lunit participates in Singapore's AI diagnostic solution project

Lunit participates in Singapore's AI diagnostic solution project

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that it solely participates in a chest X-ray reading workflow improvement project led by Singapore's National Healthcare Group (NHG).According to Lunit, Singapore's public healthcare services are divided among three he

Lunit to supply AI cancer diagnostics to Qatar

Lunit to supply AI cancer diagnostics to Qatar

Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Insight MMG for Qatar's Primary Health Care Corp. (PHCC)-led National Breast Cancer Screening Project.Qatar's PHCC recommends women aged between 45 a

Lunit eyes developing markets with AI cancer diagnostics

Lunit eyes developing markets with AI cancer diagnostics

Lunit CEO Brandon Suh Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagnostic technology and infrastructure, said its chief on Monday. “Our goal is to use AI to promote early diagnosis of bre

Lunit buys breast cancer detection AI firm Volpara Health

Lunit buys breast cancer detection AI firm Volpara Health

 Teri Thomas, chief executive of Volpara Health (left), Brandon Suh, CEO of Lunit Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection, for 264.7 bi

Lunit, Radiobotics team up to enter EMEA markets

Lunit, Radiobotics team up to enter EMEA markets

South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS to enter the Europe, Middle East, and Africa (EMEA) markets. Under the agreement, the company will distribute Radiobotics' fracture and trau

(* comment hide *}